Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/152435
Full metadata record
DC FieldValueLanguage
dc.creatorSharifi-Rad, J
dc.creatorQuispe, C
dc.creatorButnariu, M
dc.creatorRotariu, LS
dc.creatorSytar, O
dc.creatorSestito, S
dc.creatorRapposelli, S
dc.creatorAkram, M
dc.creatorIqbal, M
dc.creatorKrishna, A
dc.creatorKumar, NVA
dc.creatorBraga, SS
dc.creatorCardoso, SM
dc.creatorJafernik, K
dc.creatorEkiert, H
dc.creatorMartins, N
dc.creatorSzopa, A
dc.creatorVillagran, M
dc.creatorMardones, L
dc.creatorMartorell, M
dc.creatorDocea, AO
dc.creatorCalina, D
dc.date.accessioned2023-08-29T08:22:10Z-
dc.date.available2023-08-29T08:22:10Z-
dc.date.issued2021
dc.identifier.issn1475-2867
dc.identifier.urihttps://hdl.handle.net/10216/152435-
dc.description.abstractThe study describes the current state of knowledge on nanotechnology and its utilization in medicine. The focus in this manuscript was on the properties, usage safety, and potentially valuable applications of chitosan-based nanomaterials. Chitosan nanoparticles have high importance in nanomedicine, biomedical engineering, discovery and development of new drugs. The manuscript reviewed the new studies regarding the use of chitosan-based nanoparticles for creating new release systems with improved bioavailability, increased specificity and sensitivity, and reduced pharmacological toxicity of drugs. Nowadays, effective cancer treatment is a global problem, and recent advances in nanomedicine are of great importance. Special attention was put on the application of chitosan nanoparticles in developing new system for anticancer drug delivery. Pre-clinical and clinical studies support the use of chitosan-based nanoparticles in nanomedicine. This manuscript overviews the last progresses regarding the utilization, stability, and bioavailability of drug nanoencapsulation with chitosan and their safety.
dc.description.sponsorshipThanks are due to University of Aveiro and FCT/MCTES (Fundação para a Ciência e a Tecnologia, Ministério da Ciência, Tecnologia e Ensino Superior) for general funding to LAQV-REQUIMTE (ref UIDB/50006/2020) and to the QOPNA research unit.
dc.language.isoeng
dc.publisherBMC
dc.relation.ispartofCancer Cell International, vol.21(1):318
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectCancer
dc.subjectChitosan
dc.subjectNanomedicine
dc.subjectNanoparticles
dc.subjectTargeted therapy
dc.titleChitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.1186/s12935-021-02025-4
dc.relation.publisherversionhttps://cancerci.biomedcentral.com/articles/10.1186/s12935-021-02025-4
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.1186-s12935-021-02025-4.pdf1.16 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons